These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 31316523)

  • 1. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
    Front Immunol; 2019; 10():1489. PubMed ID: 31316523
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal histological continuum of TAFRO syndrome: A case report and literature review.
    Uemura T; Matsui M; Kokubu M; Samejima KI; Tsuruya K
    Clin Nephrol; 2022 Feb; 97(2):121-128. PubMed ID: 34854374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
    Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
    J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
    Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Mizutani KI; Kumagai M; Shioya A; Guo X; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Kida M; Yamada S
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
    CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed diagnosis of TAFRO syndrome: A case report.
    Qiao Y; Zhang X; Xu R; Jia X; Wang Q
    Medicine (Baltimore); 2024 Aug; 103(31):e39148. PubMed ID: 39093747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions.
    Hashimoto K; Sano T; Honma Y; Ida M; Tominaga H; Sawada A; Abe T; Takahashi H; Shimada Y; Masaki T; Kamata M; Naito S; Aoyama T; Takeuchi Y; Akiya M; Inukai M; Nakata N
    CEN Case Rep; 2019 Feb; 8(1):48-54. PubMed ID: 30244358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
    Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
    Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
    Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
    Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
    Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.